Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-07-07 4:01 pm Purchase |
2022-06-27 | 13G | Altimmune, Inc. ALT |
Cormorant Asset Management LP | 3,000,000 6.130% |
3,000,000![]() (New Position) |
Filing History |
2022-06-17 4:30 pm Purchase |
2021-12-31 | 13G | VectivBio Holding AG VECT |
Cormorant Asset Management LP | 2,840,389 6.160% |
2,840,389![]() (New Position) |
Filing History |
2022-06-06 5:50 pm Purchase |
2022-06-03 | 13G | Prometheus Biosciences, Inc. RXDX |
Cormorant Asset Management LP | 2,224,847 5.680% |
376,825![]() (+20.39%) |
Filing |
2022-02-14 3:18 pm Purchase |
2022-02-02 | 13G | GreenLight Biosciences Holdings GRNA |
Cormorant Asset Management LP | 9,479,058 7.720% |
9,479,058![]() (New Position) |
Filing History |
2022-02-14 3:17 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Cormorant Asset Management LP | 4,899,184 5.600% |
4,899,184![]() (New Position) |
Filing History |
2022-02-14 3:16 pm Purchase |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,381,932 9.990% |
42,301![]() (+3.16%) |
Filing History |
2022-02-14 3:15 pm Sale |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Cormorant Asset Management LP | 1,848,022 4.750% |
-250,000![]() (-11.92%) |
Filing |
2022-02-14 3:14 pm Sale |
2021-12-31 | 13G | Galecto, Inc. GLTO |
Cormorant Asset Management LP | 40,810 4.040% |
-45,220![]() (-52.56%) |
Filing History |
2022-02-14 3:13 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,639,998 9.790% |
179,998![]() (+4.04%) |
Filing History |
2022-02-14 3:12 pm Sale |
2021-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Cormorant Asset Management LP | 1,154,424 4.070% |
-750,000![]() (-39.38%) |
Filing History |
2022-02-14 3:11 pm Sale |
2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Cormorant Asset Management LP | 0 0.000% |
-2,490,065![]() (Position Closed) |
Filing History |
2022-02-14 3:10 pm Sale |
2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Cormorant Asset Management LP | 1,830,691 7.500% |
-200,000![]() (-9.85%) |
Filing History |
2022-02-14 3:10 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Cormorant Asset Management LP | 2,431,852 3.300% |
-1,243,148![]() (-33.83%) |
Filing History |
2022-02-14 3:09 pm Sale |
2021-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Cormorant Asset Management LP | 17,266,144 7.060% |
-138,558![]() (-0.80%) |
Filing History |
2022-02-14 3:08 pm Sale |
2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Cormorant Asset Management LP | 3,002,200 6.460% |
-191,774![]() (-6.00%) |
Filing History |
2022-02-14 3:08 pm Purchase |
2021-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST |
Cormorant Asset Management LP | 5,440,451 9.770% |
325,607![]() (+6.37%) |
Filing History |
2022-02-14 3:07 pm Sale |
2021-12-31 | 13G | BioAtla, Inc. BCAB |
Cormorant Asset Management LP | 2,038,215 5.770% |
-253,845![]() (-11.07%) |
Filing History |
2022-02-14 3:06 pm Sale |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,012,115 4.290% |
-452,432![]() (-18.36%) |
Filing History |
2022-02-14 3:05 pm Sale |
2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
Cormorant Asset Management LP | 1,679,442 2.020% |
-4,731,913![]() (-73.81%) |
Filing History |
2022-02-14 3:04 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Cormorant Asset Management LP | 1,436,322 6.280% |
1,436,322![]() (New Position) |
Filing History |